169 related articles for article (PubMed ID: 30885023)
1. Boron's neurophysiological effects and tumoricidal activity on glioblastoma cells with implications for clinical treatment.
Altinoz MA; Topcu G; Elmaci İ
Int J Neurosci; 2019 Oct; 129(10):963-977. PubMed ID: 30885023
[No Abstract] [Full Text] [Related]
2. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
3. [Possibilities of boron neutron capture therapy in the treatment of malignant brain tumors].
Kanygin VV; Kichigin AI; Gubanova NV; Taskaev SY
Vestn Rentgenol Radiol; 2015; (6):36-42. PubMed ID: 26999933
[TBL] [Abstract][Full Text] [Related]
4. Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT).
Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H
Appl Radiat Isot; 2014 Jun; 88():20-2. PubMed ID: 24480727
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
6. Boron concentrations in brain during boron neutron capture therapy: in vivo measurements from the phase I trial EORTC 11961 using a gamma-ray telescope.
Verbakel WF; Sauerwein W; Hideghety K; Stecher-Rasmussen F
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):743-56. PubMed ID: 12573762
[TBL] [Abstract][Full Text] [Related]
7. Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain.
Iwakura M; Kondoh H; Hiratsuka J; Ehara K; Tamaki N; Mishima Y
Pigment Cell Res; 2002 Feb; 15(1):67-75. PubMed ID: 11837459
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
[TBL] [Abstract][Full Text] [Related]
9. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
Wu G; Barth RF; Yang W; Lee RJ; Tjarks W; Backer MV; Backer JM
Anticancer Agents Med Chem; 2006 Mar; 6(2):167-84. PubMed ID: 16529539
[TBL] [Abstract][Full Text] [Related]
10. Tumor Cell-Specific 2'-Fluoro RNA Aptamer Conjugated with
Vorobyeva MA; Dymova MA; Novopashina DS; Kuligina EV; Timoshenko VV; Kolesnikov IA; Taskaev SY; Richter VA; Venyaminova AG
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298946
[TBL] [Abstract][Full Text] [Related]
11. Boron phenyl alanine targeted chitosan-PNIPAAm core-shell thermo-responsive nanoparticles: boosting drug delivery to glioblastoma in BNCT.
Soleimanbeigi M; Dousti F; Hassanzadeh F; Mirian M; Varshosaz J; Kasesaz Y; Rostami M
Drug Dev Ind Pharm; 2021 Oct; 47(10):1607-1623. PubMed ID: 35060826
[TBL] [Abstract][Full Text] [Related]
12. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
[TBL] [Abstract][Full Text] [Related]
13. Boron neutron capture therapy of primary and metastatic brain tumors.
Barth RF; Soloway AH
Mol Chem Neuropathol; 1994; 21(2-3):139-54. PubMed ID: 8086033
[TBL] [Abstract][Full Text] [Related]
14. Boron neutron capture therapy for glioblastoma.
Yamamoto T; Nakai K; Matsumura A
Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
[TBL] [Abstract][Full Text] [Related]
15. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
Bergenheim AT; Capala J; Roslin M; Henriksson R
J Neurooncol; 2005 Feb; 71(3):287-93. PubMed ID: 15735919
[TBL] [Abstract][Full Text] [Related]
16. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
H-Stenstam B
Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284
[No Abstract] [Full Text] [Related]
17. Spectromicroscopy of boron in human glioblastomas following administration of Na2B12H11SH.
Gilbert B; Perfetti L; Fauchoux O; Redondo J; Baudat PA; Andres R; Neumann M; Steen S; Gabel D; Mercanti D; Ciotti MT; Perfetti P; Margaritondo G; De Stasio G
Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics; 2000 Jul; 62(1 Pt B):1110-8. PubMed ID: 11088567
[TBL] [Abstract][Full Text] [Related]
18. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
[TBL] [Abstract][Full Text] [Related]
19. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
Nariai T; Ishiwata K; Kimura Y; Inaji M; Momose T; Yamamoto T; Matsumura A; Ishii K; Ohno K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S348-50. PubMed ID: 19375930
[TBL] [Abstract][Full Text] [Related]
20. Efficient neutron capture therapy of glioblastoma with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP).
Nishimura K; Kashiwagi H; Morita T; Fukuo Y; Okada S; Miura K; Matsumoto Y; Sugawara Y; Enomoto T; Suzuki M; Nakai K; Kawabata S; Nakamura H
J Control Release; 2023 Aug; 360():249-259. PubMed ID: 37356755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]